Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    7518658 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Condition: HIV Infections
Intervention: Drug: Didanosine
2 Completed Comparison of ddI Versus Zidovudine in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine
3 Completed A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine
To Top

† Indicates status has not been verified in more than two years